Company intelligence / Profile preview
MukoCell GmbH
Dortmund, Nordrhein-Westfalen, Germanymukocell.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Commercial
01
Overview
MukoCell therapy has shown safety and effectiveness in a 36-month follow-up period. It eliminates the need for tissue grafting from the mouth and associated complications. The therapy is currently offered to more than 200 patients by 10 specialized clinics in Germany[5].
- Therapeutic areas
- Men's Health
- Modalities
- Autologous cell therapyTissue-engineered products
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Co.don (manufacturing partner)[3]
Beyond the preview
Go deeper on MukoCell GmbH.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MukoCell GmbH.